FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Aurobindo Pharma Pain Reliever Recall

Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardb…

Aurobindo Pharma USA Inc. · East Windsor, NJ

Risk level
Class II
Reported by FDA
May 31, 2023
Recall ID
D-0765-2023
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Pain Reliever starting May 22, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0765-2023 on May 31, 2023. Reason: Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity. Status: Completed.

Why it was recalled

Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.

Product description

Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015; NDC 0363-9947-35.

Lot numbers, UPCs & expiration codes

Lot: P2200101, P2200178, Exp. date 11/2023; P2200230, Exp. date 12/2023

Where it was sold

The recalled product was distributed to one Retail Distributor (Walgreens) who further distributed Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0765-2023
Classification
Class II
Status
Completed
Recall initiated
May 22, 2023
FDA report date
May 31, 2023
Quantity
87,360 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc.

Original FDA data

Every field from FDA enforcement report D-0765-2023, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Completed
Country
United States
Event ID
92380
Address
279 Princeton Hightstown Rd
Code information
Lot: P2200101, P2200178, Exp. date 11/2023; P2200230, Exp. date 12/2023
Postal code
08520-1401
Report date
May 31, 2023
Product type
Drugs
Recall number
D-0765-2023
Classification
Class II
Recalling firm
Aurobindo Pharma USA Inc.
Product quantity
87,360 bottles
Reason for recall
Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015; NDC 0363-9947-35.
Distribution pattern
The recalled product was distributed to one Retail Distributor (Walgreens) who further distributed Nationwide in the USA.
Recall initiation date
May 22, 2023
Initial firm notification
Letter
Center classification date
May 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0765-2023, published May 31, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls